ArticleMedicine2026
1000 highly cited articles in depression research (2016-2026): A bibliometric and scoping review (global depression research: 2016-2026).
Article in Medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundDepression is one of the world's leading causes of disability, creating significant challenges for individuals and society. Although research in this field has grown rapidly, we still lack a complete understanding of how depression research has evolved globally over the past decade, especially regarding the long-term effects of the Coronavirus disease 2019pandemic.
methodsWe collected data from the Web of Science Core Collection as of April 28, 2026. After careful screening, we included 1000 highly cited articles. Using bibliometric methods and visualization tools, we analyzed collaboration networks, keyword patterns, emerging topics, and timeline developments.
resultsOur analysis shows that the United States produces more than half of the world's high-impact depression research. Research focus has shifted from traditional theories to new areas like brain-immune connections and gut bacteria, leading to comprehensive treatment approaches that combine digital technology. The Coronavirus disease 2019 pandemic served as a major turning point, significantly reshaping research priorities and accelerating the integration of medicine and data science.
conclusionsOver the past decade, depression research has dynamically evolved in response to external challenges. Exploring basic biological mechanisms and combining knowledge from different fields have become central trends. Our comprehensive analysis provides valuable insights for planning future research, developing policies, and understanding the direction toward "multimodal integration" in depression treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.